“A maladaptive pattern of substance use, leading to clinically significant impairment or distress, as manifested by three (or more) of the following, occurring at any time in the same twelve month period: i) tolerance as defined by either of the following: (a) a need for markedly increased amounts of the substance to achieve intoxication or desired effect or (b) markedly diminished effect with continued use of the same amount of the substance; ii) withdrawal as manifested by either of the following: (a) the characteristic withdrawal syndrome for the substance or (b) the same (or a closely related substance) is taken to relieve or avoid withdrawal symptoms; CT v. SSWP (ESA)[2021] UKUT 131 (AAC) CT v. SSWP (ESA) 8 CE/1632/2020 iii) the substance is often taken in larger amounts over a longer period than was intended; iv) there is a persistent desire or unsuccessful efforts to cut down or control substance use; v) a great deal of time is spent in activities necessary to obtain the substance (eg visiting multiple doctors or driving long distances), use the substance (eg. chain-smoking), or recover from its effects; vi) important social, occupational or recreational activities are given up or reduced because of substance use; vii) the substance use is continued despite knowledge of having a persistent or recurrent physical or psychological problems that is likely to have been caused or exacerbated by the substance (eg. current cocaine use despite recognition of cocaine-induced depression or continued drinking despite recognition that an ulcer was made worse by alcohol consumption).”
“a problematic pattern of opioid use leading to clinically significant impairment or distress as manifested by at least two of the following occurring within a 12 month period: i) opioids are often taken in larger amounts or over a longer period than was intended; ii) a persistent desire or unsuccessful attempts to cut down or control opiate use; iii) a great deal of time is spent in activities necessary to obtain the opioid, use the opioid or recover from its effects; iv) craving or a strong desire to use opioids; v) recurrent opioid use resulting in a failure to fulfil major role obligations at work, school or home; vi) continued opioid use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the use of opioids; CT v. SSWP (ESA)[2021] UKUT 131 (AAC) CT v. SSWP (ESA) 1 0 CE/1632/2020 vii) important social, occupational or recreational activities are given up or their engagement is reduced because of opioid use; viii) recurrent opioid use in situations in which it is physically hazardous; ix) continued opioid use despite knowledge of having a persistent or recurrent physical of psychological problem that is likely to have been caused or exacerbated by the substance; x) tolerance as defined by either a need for markedly increased amounts of opioids to achieve intoxication/desired effect or a markedly diminished effect with continued use of the same amount of opioid; xi) and withdrawal as manifested by either the characteristic opioid withdrawal syndrome or opioids (or a closely related substance) being taken to relieve or avoid withdrawal symptoms.”
"The Upper Tribunal is to be a superior court of record."